Glycomic and Proteomic Profiling of Pancreatic Cyst Fluids Identifies Hyperfucosylated Lactosamines on theN-linked Glycans of Overexpressed Glycoproteins

N-linked Glycan Structures and Their Expressions Change in the Blood Sera of Ovarian Cancer Patients

(2012) William R. Alley et al.   JOURNAL OF PROTEOME RESEARCH

Serum Biomarker Panels for the Detection of Pancreatic Cancer

(2011) R. E. Brand et al.   CLINICAL CANCER RESEARCH

Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients

(2011) Lucy A. Parker et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study

(2011) Richard Zubarik et al.   GASTROINTESTINAL ENDOSCOPY

Role of Proteomics to Differentiate between Benign and Potentially Malignant Pancreatic Cysts

(2011) Aurora Cuoghi et al.   JOURNAL OF PROTEOME RESEARCH

Mass Spectrometric Assay for Analysis of Haptoglobin Fucosylation in Pancreatic Cancer

(2011) Zhenxin Lin et al.   JOURNAL OF PROTEOME RESEARCH

Clinical Value of Serum Neopterin, Tissue Polypeptide-Specific Antigen and CA19-9 Levels in Differential Diagnosis between Pancreatic Cancer and Chronic Pancreatitis

(2011) Renata Talar-Wojnarowska et al.   PANCREATOLOGY

Prevalence of Incidental Pancreatic Cysts in the Adult Population on MR Imaging

(2010) Karen S Lee et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Chip-based Reversed-phase Liquid Chromatography−Mass Spectrometry of Permethylated N-Linked Glycans: A Potential Methodology for Cancer-biomarker Discovery

(2010) William R. Alley et al.   ANALYTICAL CHEMISTRY

Glycosylation Variants of Mucins and CEACAMs As Candidate Biomarkers for the Diagnosis of Pancreatic Cystic Neoplasms

(2010) Brian B. Haab et al.   ANNALS OF SURGERY

A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia

(2010) Miriam V. Dwek et al.   CLINICA CHIMICA ACTA

Comparison of Plasma Tu-M2-PK and CA19-9 in Pancreatic Cancer

(2010) Maiken Thyregod Joergensen et al.   PANCREAS

Software Tool for Researching Annotations of Proteins: Open-Source Protein Annotation Software with Data Visualization

(2009) Vivek N. Bhatia et al.   ANALYTICAL CHEMISTRY

The Prevalence and Nature of Glycan Alterations on Specific Proteins in Pancreatic Cancer Patients Revealed Using Antibody-Lectin Sandwich Arrays

(2009) Tingting Yue et al.   MOLECULAR & CELLULAR PROTEOMICS

Serine Protease Inhibitor Kazal Type 1 Promotes Proliferation of Pancreatic Cancer Cells through the Epidermal Growth Factor Receptor

(2009) N. Ozaki et al.   MOLECULAR CANCER RESEARCH

Proteomic Analyses of Pancreatic Cyst Fluids

(2009) Eileen Ke et al.   PANCREAS

A Compendium of Potential Biomarkers of Pancreatic Cancer

(2009) H. C. Harsha et al.   PLOS MEDICINE

Serum fucosylation changes in oral cancer and oral precancerous conditions

(2008) Manisha Shah et al.   CANCER

Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles

(2008) Z. Kyselova et al.   CLINICAL CHEMISTRY

Prognosis of Resected Ampullary Adenocarcinoma by Preoperative Serum CA19-9 Levels and Platelet-Lymphocyte Ratio

(2008) Richard A. Smith et al.   JOURNAL OF GASTROINTESTINAL SURGERY

ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics

(2008) Benjamin Mann et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY